SHERI MOORE: Open Payments
NPI 1790196111 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 17 payments from 12 companies in 2025. Trend: 2023 $42 · 2024 $0 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 1 | $88 |
| ABBVIE INC. | 2 | $54 |
| Novo Nordisk Inc | 2 | $40 |
| Lilly USA, LLC | 2 | $40 |
| Inspire Medical Systems, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Amgen Inc. | 2 | $29 |
| Abbott Laboratories | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $21 |
Products named: ZORYVE, INSPIRE, QULIPTA, TRINTELLIX, PURIFIED CORTROPHIN GEL, OTEZLA, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across VA — which companies pay providers there.
